One of the biggest trends playing out right now is the aging U.S. population, with baby boomers retiring over the next decade or two. One of the ways to play that wave is through national lab-testing companies Quest Diagnostics and LabCorp.
Lab testing accounts for 2% to 3% of health-care spending, yet it influences 70% to 80% of health-care decisions. As the two national players in the space, Quest and LabCorp present an interesting investment opportunity. Both companies are well run, trade at reasonable multiples, and enjoy advantages of scale and scope. Watch the video for the full details.
If you're looking for some long-term investing ideas, read the Fool's brand-new special report: "The 3 Dow Stocks Dividend Investors Need." It's absolutely free, so just click here and get your copy today.
Matthew Argersinger has options on Johnson & Johnson. Paul Chi has no positions in the stocks mentioned above. The Motley Fool owns shares of Abbott Laboratories and Johnson & Johnson. Motley Fool newsletter services recommend Johnson & Johnson, Laboratory of America, Quest Diagnostics, and UnitedHealth Group. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.